Cost-effectiveness of Prednisolone to Treat Bell Palsy in Children: An Economic Evaluation Alongside a Randomized Controlled Trial

Bell palsy is the third most frequent diagnosis in children with sudden-onset neurologic dysfunction. The cost-effectiveness of treating Bell palsy with prednisolone in children is unknown. We aimed to assess the cost-effectiveness of prednisolone in treating Bell palsy in children compared with pla...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurology 2023-06, Vol.100 (24), p.e2432-e2441
Hauptverfasser:	Xiong, Xiuqin, Huang, Li, Herd, David W., Borland, Meredith L., Davidson, Andrew, Hearps, Stephen, Mackay, Mark T., Lee, Katherine J., Dalziel, Stuart R., Dalziel, Kim, Cheek, John A., Babl, Franz E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Australia Bell Palsy - diagnosis Child Cost-Benefit Analysis Drug Therapy, Combination Humans Prednisolone - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Bell palsy is the third most frequent diagnosis in children with sudden-onset neurologic dysfunction. The cost-effectiveness of treating Bell palsy with prednisolone in children is unknown. We aimed to assess the cost-effectiveness of prednisolone in treating Bell palsy in children compared with placebo. This economic evaluation was a prospectively planned secondary analysis of a double-blinded, randomized, placebo-controlled superiority trial (Bell Palsy in Children [BellPIC]) conducted from 2015 to 2020. The time horizon was 6 months since randomization. Children aged 6 months to
ISSN:	0028-3878 1526-632X
DOI:	10.1212/WNL.0000000000207284